Global footprint Inovet operates across Belgium, France, Hungary and Vietnam with a production facility in France and toll manufacturing capabilities, indicating a multinational reach and potential for cross-market veterinary product distribution and collaboration opportunities.

Acquisition backing Now part of the Orion Group since 2022, Inovet benefits from backing of a larger pharma parent, which may facilitate partnerships, broader financing for product launches, and expanded sales channels in international markets.

Extensive catalog With over 220 products and more than 1,200 international marketing authorizations under two major brands, there are numerous entry points for sales through existing channels, co-marketing, or line extensions in companion animal and livestock segments.

Manufacturing strength A dedicated France production facility with multiple units for injectables, oral solutions, premixes and complementary feeds, plus toll manufacturing capabilities, creates opportunities for private-label partnerships, contract manufacturing deals, and accelerated time-to-market for new formulations.

Product momentum Recent product launches such as ATOP 7 spot-on and participation in international poultry events suggest active product development and market engagement, signaling potential for category expansion in parasiticides, dermatology, and poultry health in target regions.